CN105462868A - Method for improving yield and production intensity of pyruvic acid - Google Patents

Method for improving yield and production intensity of pyruvic acid Download PDF

Info

Publication number
CN105462868A
CN105462868A CN201510907318.2A CN201510907318A CN105462868A CN 105462868 A CN105462868 A CN 105462868A CN 201510907318 A CN201510907318 A CN 201510907318A CN 105462868 A CN105462868 A CN 105462868A
Authority
CN
China
Prior art keywords
mpc1
pyruvic acid
recombinant bacterium
acid
tgu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510907318.2A
Other languages
Chinese (zh)
Other versions
CN105462868B (en
Inventor
周景文
陈坚
罗正山
堵国成
刘松
方芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN201510907318.2A priority Critical patent/CN105462868B/en
Publication of CN105462868A publication Critical patent/CN105462868A/en
Application granted granted Critical
Publication of CN105462868B publication Critical patent/CN105462868B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids

Abstract

The invention discloses a method for improving the yield and production intensity of pyruvic acid, and belongs to the technical field of fermentation engineering. According to the method, pyruvic acid carrier proteins of mitochondria are over-expressed in a torulopsis glabrata strain, and enhanced pyruvic acid enters the mitochondria to further enhance the growth of the torulopsis glabrata, so that the yield and production intensity of a growth-related type product, namely, pyruvic acid are improved; MPC1 genes from saccharomyces cerevisiae are over-expressed in TgU- through a genetic engineering technology to obtain an engineering strain TgU-(pY26-MPC1) highly producing pyruvic acid; and compared with a reference strain TgU-(pY26), the dry cell weight, glucose consumption rate, pyruvic acid yield and pyruvic acid production intensity of the engineering strain TgU-(pY26-MPC1) are improved by 24.9%, 28.2%, 91.9% and 94.1% respectively.

Description

A kind of method improving output of pyruvic acid and production intensity
Technical field
The present invention relates to a kind of method improving output of pyruvic acid and production intensity, belong to fermentation engineering field.
Background technology
Pyruvic acid (pyruvate) is the intermediate product of biological metabolism, is in the middle-chain of each pathways metabolism, as: be glucolytic end product; Initial substance acetyl-the CoA of TCA circulation is converted into by dehydrogenation decarboxylic reaction; The intermediate product oxaloacetic acid of TCA circulation is generated under pyruvate carboxylase effect; Generate L-Ala etc. by transamination, be also one of very important ketone acid simultaneously.Due to the synthesis precursor that pyruvic acid is many kinds of substance, the demand of present society to pyruvic acid increases day by day, and it is widely used in daily use chemicals, food, medical treatment, the industries such as agricultural.
The production method of pyruvic acid mainly contains chemical synthesis and the large class of microbe fermentation method two.Chemical synthesis mainly contain winestone acid system, the cruel air oxidation process of lactic acid second, through benzylacetone method, electrochemical synthesis, lactic acid catalytic oxidation.The just former chemical industry synthesis of the production of current pyruvic acid turns to be prepared by fermentable.Microbe fermentation method has more advantage relative to chemical industry synthesis, and the transformation efficiency as raw material is high, pollutes little, low cost and other advantages.
At present, Production by Microorganism Fermentation pyruvic acid becomes the hot topic of research both at home and abroad as a kind of substituting environmental protection method.And high yield pyruvic acid to be obtained by fermentable, wherein most critical to have a plant height to produce and the pyruvic acid bacterial strain of high production intensity.At present the transformation of high yield pyruvic acid bacterial strain is mainly concentrated on and process LAN is carried out to some key enzyme in pathways metabolism and some alternative pathways are pounded out.
Summary of the invention
In order to solve the problem, the invention provides and a kind ofly strengthen the production intensity of pyruvate fermentation and the method for output by process LAN mitochondrial pyruvate acid vectors albumen.
First object of the present invention is to provide a kind of method improving output of pyruvic acid and production intensity, and described method is process LAN mitochondrial pyruvate acid vectors albumen in Pyruvate production bacterial strain.
In one embodiment of the invention, described method is the mitochondrial pyruvate acid vectors albumen MPC1 expressing GeneID:852800 on NCBI.
In one embodiment of the invention, described production bacterial strain is that the torulopsis glabrata T.glabrataCCTCCM202019 having lacked Ura gene obtains for the MPC1 of GeneID:852800 on host expresses NCBI.
In one embodiment of the invention, described process LAN is for carrier with expression plasmid of yeast pY26 (purchased from moral precious company).
Second object of the present invention is to provide the recombinant bacterium of a kind of output of pyruvic acid and production intensity raising, described recombinant bacterium process LAN mitochondrial pyruvate acid vectors albumen MPC1.
In one embodiment of the invention, described recombinant bacterium is the MPC1 that the T.glabrataCCTCCM202019 having lacked Ura gene is host, expression plasmid of yeast pY26 is GeneID:852800 on vector expression NCBI.
In one embodiment of the invention, the structure of described recombinant bacterium: by object fragment MPC1 after restriction enzyme EcoRI and XamI is double digested, and MPC1 is cloned in the double digested expression plasmid pY26 of EcoRI/XamI, obtain expression of recombinant yeast plasmid pY26-MPC1, recombinant plasmid is transferred to recipient bacterium T.glabrataCCTCCM202019 (TgU by electroporated method -), screen in not containing the substratum of uridylic, obtain the recombinant bacterium TgU of mitochondrial pyruvate acid vectors albumen overexpression -(pY26-MPC1).
In one embodiment of the invention, described MPC1 gene with Wine brewing yeast strain N85 genome for template amplification obtains.
In one embodiment of the invention, described expression plasmid of yeast pY26 is the shuttle vectors between E. coli-Yeast, and in intestinal bacteria, selective marker is amp r, and selective marker is that uracil-deficient type is complementary in yeast.
3rd object of the present invention is to provide a kind of method utilizing the acid of described recombinant bacterium fermentation production of acetone, is to be seeded to fermention medium after being activated by recombinant bacterium, at 30 DEG C, carries out fermentation culture under 220rpm condition.
In one embodiment of the invention, described fermention medium (/L): glucose 120g, urea 3.86g, MgSO 4.7H 2o0.8g, KH 2pO 42g, CH 3cOONa3g, liquid microelement 10ml, VITAMIN liquid 10ml, initial pH=5.5; Described liquid microelement: MnCl 24H 2o12g, FeSO 47H 2o2g, CaCl 22H 2o2g, CuSO 45H 2o0.05g, ZnCl 20.5g, is settled to 1L after dissolving with the HCl of 2mol/L; Described VITAMIN liquid: vitamin H 0.004g, VitB1 0.75mg, pyridoxol 0.04g, nicotinic acid 0.8g, be settled to 1L after dissolving with the HCl of 2mol/L.
In one embodiment of the invention, the inoculum size of described inoculation is 10%.
Beneficial effect:
The inventive method can improve output of pyruvic acid and production intensity; Relative to control strain (TgU -(pY26)), the recombinant bacterial strain TgU of the present invention's structure -(pY26-MPC1) output of dry cell weight, glucose consumption rate, pyruvic acid and Pyruvate production intensity improve 24.9%, 28.2%, 91.9% and 94.1% respectively.
Embodiment
Bacterial strain and plasmid: torulopsis glabrata (T.glabrataCCTCCM202019, TgU -) it is nicotinic acid, vitamin H, VitB1, pyridoxine hydrochloride, uridylic 5 kinds of auxotrophic strains (namely having knocked out Ura gene on the basis of T.glabrataCCTCCM202019).Expression plasmid of yeast pY26 is the shuttle vectors between E. coli-Yeast, and in intestinal bacteria, selective marker is amp r, and selective marker is that uracil-deficient type is complementary in yeast.
The mensuration of dry cell weight: get a certain amount of bacteria suspension in 10mL volumetric flask, add 2mL hydrochloric acid (2mol/L) and dissolve calcium carbonate in suspension, add deionized water constant volume to 10mL, abundant mixing, with UV7500 type visible spectrophotometer, measure OD value in 660nm place, utilize dry cell weight typical curve to calculate dry cell weight.
The mensuration of pyruvic acid and glucose: high performance liquid chromatography (HPLC).Instrument: Agilent1260 high performance liquid chromatograph (joining UV-vis detector, differential refraction detector and workstation), chromatographic condition: chromatographic column: AminexHPX-87Hionexchangecolumn, moving phase: 5mMH 2sO 4flow velocity: 0.6mL/min, column temperature: 40 DEG C, sample size: 10 μ L, UV-detector wavelength: 210nm (detection pyruvic acid), differential refraction detector: detect glucose, sample preparation: 1mL fermented liquid is in 12, centrifugal 5min under 000rpm, supernatant, through suitable dilution process with after 0.22 μ L membrane filtration, carries out efficient liquid phase chromatographic analysis.
Substratum: seed culture medium (g/L): glucose 30g, phytone 10g, potassium primary phosphate 1.0g, magnesium sulfate heptahydrate 0.5g, solid medium adds 20g agar.115 DEG C of sterilizing 15min.Fermention medium (g/L): glucose 120g, urea 3.86g, MgSO 4.7H2O0.8g, KH 2pO 42g, CH 3cOONa3g, liquid microelement (filtration sterilization) 10ml, VITAMIN liquid (filtration sterilization) 10ml, sterilizing 15min at 115 DEG C.The calcium carbonate (independent sterilizing) of 40g/L is added for regulating pH.Liquid microelement: MnCl 24H 2o12g, FeSO 47H 2o2g, CaCl 22H 2o2g, CuSO 45H 2o0.05g, ZnCl 20.5g, is settled to 1L after dissolving with the HCl of 2mol/L.VITAMIN liquid: vitamin H 0.004g, VitB1 0.75mg, pyridoxol 0.04g, nicotinic acid 0.8g, be settled to 1L after dissolving with the HCl of 2mol/L.
Embodiment 1: the amplification of yeast saccharomyces cerevisiae MPC1 and the structure of expression plasmid
With genes of brewing yeast group for template, pcr amplification obtains goal gene MPC1 fragment, the specific fragment of about 400bp is obtained by agarose gel electrophoresis, goal gene MPC1 is after restriction enzyme EcoRI and XamI is double digested, concentrated and purified, by MPC1, MPC2 gene directed cloning in expression plasmid pY26, obtain expression of recombinant yeast plasmid pY26-MPC1, above-mentioned recombinant expression plasmid is transformed into competent cell JM109 and is coated on the LB flat board containing penbritin and increase.
Embodiment 2: the Construction and identification of recombinant bacterium
Due on above-mentioned recombinant plasmid with Ura3 gene, above-mentioned recombination yeast plasmid is electroporated to recipient bacterium T.glabrata (Ura-) (namely having lacked the T.glabrataCCTCCM202019 of Ura gene) respectively, obtain the recombinant bacterium TgU of normal growth on the basic medium not adding uridylic -(pY26-MPC1)
Embodiment 3: recombinant bacterium with contrast bacterium control fermentation and test
Picking recombinant bacterium TgU -(pY26-MPC1) T.glabrata (Ura with containing empty plasmid pY26 -) single bacterium colony activation culture 18-24h on seed culture medium, with the inoculum size of 10%, the seed liquor that above-mentioned activation culture is good is inoculated in fermention medium, at 30 DEG C, under 220rpm condition, carries out fermentation culture.Fermentation results is as shown in table 1, and the output of the dry cell weight of recombinant bacterium, glucose consumption rate, pyruvic acid and Pyruvate production intensity are relative to contrast bacterium (TgU -(pY26)) improve 24.9%, 28.2%, 91.9% and 94.1% respectively.
Table 1 recombinant bacterium TgU -(pY26-MPC1) with contrast bacterium TgU -(pY26) fermentation contrast
Although the present invention with preferred embodiment openly as above; but it is also not used to limit the present invention, any person skilled in the art, without departing from the spirit and scope of the present invention; all can do various changes and modification, what therefore protection scope of the present invention should define with claims is as the criterion.

Claims (10)

1. a recombinant bacterium for output of pyruvic acid and production intensity raising, is characterized in that, described recombinant bacterium process LAN mitochondrial pyruvate acid vectors albumen MPC1.
2. recombinant bacterium according to claim 1, is characterized in that, described recombinant bacterium has lacked the MPC1 that the torulopsis glabrata T.glabrataCCTCCM202019 of Ura gene is GeneID:852800 on host expresses NCBI.
3. recombinant bacterium according to claim 1, is characterized in that, described process LAN is for carrier with expression plasmid of yeast pY26.
4. recombinant bacterium according to claim 1, it is characterized in that, the structure of described recombinant bacterium: by object fragment MPC1 after restriction enzyme EcoRI and XamI is double digested, and by MPC1 directed cloning in expression plasmid pY26, obtain expression of recombinant yeast plasmid pY26-MPC1, recombinant plasmid is transferred in uracil auxotrophy recipient bacterium by electroporated method, screen in not containing the substratum of uridylic, obtain the recombinant bacterium TgU of mitochondrial pyruvate acid vectors albumen overexpression -(pY26-MPC1).
5. improve a method for output of pyruvic acid and production intensity, it is characterized in that, described method is process LAN mitochondrial pyruvate acid vectors albumen in Pyruvate production bacterial strain.
6. method according to claim 5, is characterized in that, described method is the mitochondrial pyruvate acid vectors albumen MPC1 expressing GeneID:852800 on NCBI.
7. the application of the arbitrary described recombinant bacterium of claim 1-4 in fermentation production of acetone acid.
8. application according to claim 7, is characterized in that, described application is seeded to fermention medium after being activated by recombinant bacterium, at 30 DEG C, carries out fermentation culture under 220rpm condition.
9. application according to claim 8, is characterized in that, contains: glucose 120g, urea 3.86g, MgSO in described fermention medium 1L 4.7H 2o0.8g, KH 2pO 42g, CH 3cOONa3g, liquid microelement 10ml, VITAMIN liquid 10ml, initial pH=5.5; Described liquid microelement: MnCl 24H 2o12g, FeSO 47H 2o2g, CaCl 22H 2o2g, CuSO 45H 2o0.05g, ZnCl 20.5g, is settled to 1L after dissolving with the HCl of 2mol/L; Described VITAMIN liquid: vitamin H 0.004g, VitB1 0.75mg, pyridoxol 0.04g, nicotinic acid 0.8g, be settled to 1L after dissolving with the HCl of 2mol/L.
10. the pyruvic acid produced of the arbitrary described recombinant bacterium of claim 1-4 at daily use chemicals, food, prepare the application of medicine, agriculture field.
CN201510907318.2A 2015-12-10 2015-12-10 A method of improving output of pyruvic acid and production intensity Active CN105462868B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510907318.2A CN105462868B (en) 2015-12-10 2015-12-10 A method of improving output of pyruvic acid and production intensity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510907318.2A CN105462868B (en) 2015-12-10 2015-12-10 A method of improving output of pyruvic acid and production intensity

Publications (2)

Publication Number Publication Date
CN105462868A true CN105462868A (en) 2016-04-06
CN105462868B CN105462868B (en) 2019-02-22

Family

ID=55601030

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510907318.2A Active CN105462868B (en) 2015-12-10 2015-12-10 A method of improving output of pyruvic acid and production intensity

Country Status (1)

Country Link
CN (1) CN105462868B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106544285A (en) * 2016-12-07 2017-03-29 江南大学 A kind of reinforcing torulopsis glabrata synthesis Pyruvate Method
CN106544286A (en) * 2016-12-07 2017-03-29 江南大学 It is a kind of to reduce the method that polysaccharide accumulation reinforcing torulopsis glabrata produces pyruvic acid

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101245322A (en) * 2008-03-18 2008-08-20 江南大学 Construction of bacterial strain producing pyruvic acid recombination and method for improving production strength of pyruvic acid
CN101691545A (en) * 2009-09-09 2010-04-07 江南大学 Structuring of pyruvic acid-producing recombinant bacteria strain and method for enhancing synthesis rate of pyruvic acid by pyruvic acid-producing recombinant bacteria
CN103710274A (en) * 2013-12-24 2014-04-09 江南大学 Genetically engineered bacterium for increasing yield of extracellular pyruvic acid and application thereof
US20150087032A1 (en) * 2013-09-25 2015-03-26 Samsung Electronics Co., Ltd. Yeast cell with increased pyruvate pool in cytosol and method of producing pyruvate-based metabolite using the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101245322A (en) * 2008-03-18 2008-08-20 江南大学 Construction of bacterial strain producing pyruvic acid recombination and method for improving production strength of pyruvic acid
CN101691545A (en) * 2009-09-09 2010-04-07 江南大学 Structuring of pyruvic acid-producing recombinant bacteria strain and method for enhancing synthesis rate of pyruvic acid by pyruvic acid-producing recombinant bacteria
US20150087032A1 (en) * 2013-09-25 2015-03-26 Samsung Electronics Co., Ltd. Yeast cell with increased pyruvate pool in cytosol and method of producing pyruvate-based metabolite using the same
CN103710274A (en) * 2013-12-24 2014-04-09 江南大学 Genetically engineered bacterium for increasing yield of extracellular pyruvic acid and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DANIEL K. BRICKER等: "A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans", 《SCIENCE》 *
刘立明 等: "光滑球拟酵母发酵生产丙酮酸", 《精细与专用化学品》 *
刘立明: "光滑球拟酵母中糖酵解效率与丙酮酸合成的调控研究", 《中国优秀博硕士学位论文全文数据库(博士) 工程科技I辑》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106544285A (en) * 2016-12-07 2017-03-29 江南大学 A kind of reinforcing torulopsis glabrata synthesis Pyruvate Method
CN106544286A (en) * 2016-12-07 2017-03-29 江南大学 It is a kind of to reduce the method that polysaccharide accumulation reinforcing torulopsis glabrata produces pyruvic acid
CN106544286B (en) * 2016-12-07 2019-05-10 江南大学 A method of it reducing polysaccharide accumulation and strengthens torulopsis glabrata production pyruvic acid
CN106544285B (en) * 2016-12-07 2019-07-02 江南大学 A kind of reinforcing torulopsis glabrata synthesis Pyruvate Method

Also Published As

Publication number Publication date
CN105462868B (en) 2019-02-22

Similar Documents

Publication Publication Date Title
CN106544284B (en) A kind of recombination Yarrowia lipolytica engineered strain and its construction method and application
CN105400796A (en) Gene for adjusting and controlling production of long-chain diacid and application of gene
CN110272858B (en) Bacillus coagulans for high yield of L-lactic acid and application thereof
CN109715783A (en) The method for producing lactic acid
CN105087529A (en) Genetically engineered protease K and production method of protease K
CN102994539A (en) Method for enhancing expression of corynebacterium crenatum NAD kinase to improve production capacity of strain L-arginine under high-low oxygen supply conditions
CN105368884B (en) The recombinant bacterium and its application that a kind of Pyruvate production intensity improves
CN105238797B (en) A kind of mutator of gshF genes of Streptococcusagalactiae and its application
CN102517303B (en) Recombination blue-green alga for producing lactic acid as well as preparation method and applications thereof
CN107058144A (en) A kind of restructuring yeast strains for producing itaconic acid and its construction method and application
CN105462868A (en) Method for improving yield and production intensity of pyruvic acid
CN109536427A (en) A kind of engineering lactic acid bacteria that acid stress resistance improves
CN101613707B (en) Method for producing glutathione by use of metabolic engineering bacteria
CN103451201A (en) Extreme halophilic archaea engineering bacteria for producing bioplastics PHBV by effectively utilizing carbon source
CN108641992A (en) The riboflavin-produced engineering bacteria of high temperature and its construction method and application
CN103710274A (en) Genetically engineered bacterium for increasing yield of extracellular pyruvic acid and application thereof
CN106148255B (en) Engineering bacteria lacking organic acid production way and application thereof in co-production of 1, 3-propylene glycol, 2, 3-butanediol and ethanol
CN102559730A (en) Method for increasing expression of CP4-EPSPS in Hansenula polymorpha
CN105062981A (en) Pyruvate carboxylase mutant N315F with improved enzymatic activity and application of pyruvate carboxylase mutant N315F
CN106635852B (en) A kind of recombination torulopsis glabrata of cogeneration of propanone acid and α-ketoglutaric acid
CN104611284A (en) Strain for production of cyclodextrin glucosyltransferase and application of strain
CN104046572A (en) Saccharomyces cerevisiae capable of reducing biogenic amine in yellow rice wine and its construction method and application
CN105154360B (en) A kind of cultural method of Comamonas testosteroni HY-08D
CN107586814A (en) A kind of method of glutathion production by fermentation
CN105132388A (en) Pyruvate carboxylase mutant R485P with improved enzymatic activity and application of mutant

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant